Pacira Pharmaceuticals(DE:82P)
€32.400.00 (0.00%)
DE:82P
Pacira Pharmaceuticals earnings date
€32.40
At close:0.00 (0.00%)
Pacira Pharmaceuticals (82P) Q2 2023 Earnings Report
0 Followers
DE:82P Q2 2023 EPS Results
- Actual EPS
- EUR 0.70
- Consensus EPS
- EUR 0.68
- Beat/Miss
- Beat by +EUR 0.02
- One Year Ago EPS
- EUR 0.46
DE:82P Q2 2023 Revenue Results
- Actual Revenue
- EUR 151.73M
- Expected Revenue
- EUR 156.56M
- Beat/Miss
- Missed by -EUR 4.82M
- YoY Revenue Growth
- +0.03%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/02/2023
- Time
- Before Open
- Conference Call
- Wednesday, August 2, 2023
DE:82P Upcoming Earnings
Pacira Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
DE:82P Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:82P Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | ―- | 0.51 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 0.670.62 | 0.63 | -0.29% (-0.00) | |
| Aug 04, 2026 | 2026 (Q2) | 0.580.65 | 0.66 | -1.35% (-0.01) | |
| Apr 30, 2026 | 2026 (Q1) | 0.490.54 | 0.56 | -3.23% (-0.02) | |
| Feb 26, 2026 | 2025 (Q4) | 0.810.51 | 0.81 | -37.36% (-0.30) | |
| Nov 06, 2025 | 2025 (Q3) | 0.610.63 | 0.71 | -11.39% (-0.08) | |
| Aug 05, 2025 | 2025 (Q2) | 0.640.66 | 0.8 | -16.85% (-0.13) | |
| May 08, 2025 | 2025 (Q1) | 0.530.56 | 0.56 | 0.00% (+0.00) | |
| Feb 27, 2025 | 2024 (Q4) | 0.750.81 | 0.8 | 2.25% (+0.02) | |
| Nov 06, 2024 | 2024 (Q3) | 0.630.71 | 0.64 | 9.72% (+0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

